Prospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jul 7, 2015; 21(25): 7851-7859
Published online Jul 7, 2015. doi: 10.3748/wjg.v21.i25.7851
Figure 1
Figure 1 Colon area is scanned with the TRIMprob while the patient remains normally dressed and standing approximately 2 m in front of the receiver placed at the level of abdominal wall.
Figure 2
Figure 2 TRIMprob Medical Device. The system is composed of the exploratory probe, the receiver (a spectrum analyzer), and a computer with dedicated software to record patient information and store TRIMprob data.
Figure 3
Figure 3 Colon cancer as observed by colonoscopy and by the TRIMprob. Spectral lines A, B and C correspond to the red, green and blue bars respectively in D. The interaction between the electromagnetic field emitted by the probe and cancerous tissue results in a significant decrease of 40 dBm at 465 MHz (first spectral line), a modest attenuation at 930 MHz (second spectral line); and at 1395 MHz (third spectral line).